Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases
A. Trachalaki (Herakleion, Greece), E. Tsitoura (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), E. Bibaki (Herakleion, Greece), G. Papastratigakis (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), N. Tzanakis (Herakleion, Greece), K. Antoniou (Herakleion, Greece)
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Trachalaki (Herakleion, Greece), E. Tsitoura (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), E. Bibaki (Herakleion, Greece), G. Papastratigakis (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), N. Tzanakis (Herakleion, Greece), K. Antoniou (Herakleion, Greece). Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases. 4813
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017
CX3CR1–fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases Source: Eur Respir J, 55 (2) 1900460; 10.1183/13993003.00460-2019 Year: 2020
Contribution of myeloperoxidase to inflammatory processes in lung epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 853s Year: 2006
LSC - 2019 - Inflammasomes’ activation in alveolar macrophages and peripheral blood mononuclear cells in fibrotic Interstitial Lung Diseases Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019
Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease Year: 2004
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006
Chemokine receptor expression and function of infiltrated neutrophils in inflammatory lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 856s Year: 2006
Phenotypic analysis of BAL lympocytes and respiratory function in chronic inflammatory lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease in vitro Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
Compartimentalized in-vitro TNF-α production of alveolar macrophages and peripheral mononuclear cells after severe trauma Source: Eur Respir J 2001; 18: Suppl. 33, 317s Year: 2001
Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006
Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005
Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Comparison of peripheral lung and airway tissue inflammation Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010
Inflammasome activation in airway macrophages and the lung microbiome in IPF Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020
Regulation of pulmonary inflammation and its consequences by collectins and apoptotic cells Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004
A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages Source: Eur Respir J, 55 (1) 1900646; 10.1183/13993003.00646-2019 Year: 2020